Clinical and preclinical studies reported increased complement proteins in the brain and CSF in amyotrophic lateral sclerosis, stroke, epilepsy, traumatic brain injury, multiple sclerosis, and Alzheimer’s disease (reviewed in refs. 8,12). The gene discussed is VTN; the disease is Alzheimer disease.